IMMUNOVANT INC 45258J102 08/12/2024 To approve, on a non-binding, advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 44380 0 FOR 44380 FOR HUMANA INC. 444859102 04/17/2025 Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2025 proxy statement SECTION 14A SAY-ON-PAY VOTES 12643 0 FOR 12643 FOR INTUITIVE SURGICAL, INC. 46120E602 05/01/2025 To approve, by advisory vote, the compensation of the Company's Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 5077 0 FOR 5077 FOR ELI LILLY AND COMPANY 532457108 05/05/2025 Approval, on an advisory basis, of the compensation paid to the company's named executive officers SECTION 14A SAY-ON-PAY VOTES 3978 0 FOR 3978 FOR BRISTOL-MYERS SQUIBB COMPANY 110122108 05/02/2025 Advisory Vote to Approve the Compensation of our Named Executive Officers SECTION 14A SAY-ON-PAY VOTES 38056 0 FOR 38056 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement SECTION 14A SAY-ON-PAY VOTES 262374 0 FOR 262374 FOR TRAVERE THERAPEUTICS, INC. 89422G107 05/15/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 67992 0 FOR 67992 FOR CORBUS PHARMACEUTICALS HOLDINGS, INC. 21833P301 05/15/2025 Approval, on an advisory basis, of the executive compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 188100 0 FOR 188100 FOR PERSONALIS, INC. 71535D106 05/16/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 121099 0 FOR 121099 FOR REPLIGEN CORPORATION 759916109 05/15/2025 Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers SECTION 14A SAY-ON-PAY VOTES 11158 0 FOR 11158 FOR GERON CORPORATION 374163103 05/21/2025 To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement SECTION 14A SAY-ON-PAY VOTES 2281328 0 AGAINST 2281328 FOR NUVATION BIO INC. 67080N101 05/21/2025 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES 555376 0 FOR 555376 FOR GE HEALTHCARE TECHNOLOGIES INC. 36266G107 05/28/2025 Approval of our named executive officers' compensation in an advisory vote SECTION 14A SAY-ON-PAY VOTES 18027 0 FOR 18027 FOR SCHOLAR ROCK HOLDING CORPORATION 80706P103 05/22/2025 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 43795 0 FOR 43795 FOR BEIGENE LTD 07725L102 05/12/2025 On a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved SECTION 14A SAY-ON-PAY VOTES 6500 0 FOR 6500 FOR Issuer name change to: BeOne Medicines Ltd. CYTOKINETICS, INCORPORATED 23282W605 05/14/2025 To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement SECTION 14A SAY-ON-PAY VOTES 74978 0 FOR 74978 FOR 89BIO, INC. 282559103 05/28/2025 Approval of, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 255795 0 FOR 255795 FOR DYNE THERAPEUTICS, INC. 268180403 05/30/2025 To vote, on an advisory basis, to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 232128 0 FOR 232128 FOR PENUMBRA, INC. 70975L107 05/28/2025 To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 6410 0 FOR 6410 FOR SYNDAX PHARMACEUTICALS, INC 87164F105 05/14/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement SECTION 14A SAY-ON-PAY VOTES 224273 0 FOR 224273 FOR REGENXBIO INC. 75901B107 05/30/2025 Advisory vote on the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 396749 0 FOR 396749 FOR ESTABLISHMENT LABS HOLDINGS INC. G31249108 05/23/2025 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 13100 0 FOR 13100 FOR COGENT BIOSCIENCES, INC. 19240Q201 06/04/2025 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 489198 0 FOR 489198 FOR APREA THERAPEUTICS, INC. 03836J201 06/05/2025 To approve, by non-binding advisory vote, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 25872 0 FOR 25872 FOR DISC MEDICINE, INC. 254604101 06/11/2025 To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 46322 0 FOR 46322 FOR BIOCRYST PHARMACEUTICALS, INC. 09058V103 06/11/2025 To hold a non-binding, advisory vote regarding executive compensation SECTION 14A SAY-ON-PAY VOTES 132884 0 FOR 132884 FOR IONIS PHARMACEUTICALS, INC. 462222100 06/05/2025 To make an advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 121116 0 FOR 121116 FOR NEKTAR THERAPEUTICS 640268306 05/23/2025 To approve a non-binding advisory resolution regarding our executive compensation SECTION 14A SAY-ON-PAY VOTES 1575282 0 FOR 1575282 FOR SAVARA INC. 805111101 06/05/2025 To approve, on an advisory basis, the compensation of our named executives SECTION 14A SAY-ON-PAY VOTES 577908 0 FOR 577908 FOR GUARDANT HEALTH, INC. 40131M109 06/18/2025 Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation SECTION 14A SAY-ON-PAY VOTES 97496 0 FOR 97496 FOR TREVI THERAPEUTICS INC 89532M101 06/11/2025 Approval, on an advisory basis, of the compensation paid to our named executive officers SECTION 14A SAY-ON-PAY VOTES 156854 0 FOR 156854 FOR CRINETICS PHARMACEUTICALS INC. 22663K107 06/11/2025 To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES 25834 0 FOR 25834 FOR VIRIDIAN THERAPEUTICS, INC. 92829J104 06/20/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 176218 0 FOR 176218 FOR PRAXIS PRECISION MEDICINES, INC. 74006W207 06/26/2025 To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion SECTION 14A SAY-ON-PAY VOTES 52803 0 FOR 52803 FOR NATERA, INC. 632307104 06/13/2025 To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 14961 0 FOR 14961 FOR AKEBIA THERAPEUTICS, INC. 00972D105 06/10/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers, as described in the Company's Proxy Statement SECTION 14A SAY-ON-PAY VOTES 142130 0 FOR 142130 FOR ARVINAS, INC. 04335A105 06/25/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES 167295 0 FOR 167295 FOR EDGEWISE THERAPEUTICS INC 28036F105 06/13/2025 Conduct an advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 28596 0 FOR 28596 FOR STRUCTURE THERAPEUTICS, INC 86366E106 06/16/2025 To approve, on an advisory basis, the compensation of the company's named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 77374 0 FOR 77374 FOR ANAPTYSBIO, INC. 032724106 06/17/2025 To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials SECTION 14A SAY-ON-PAY VOTES 97696 0 FOR 97696 FOR UNITED THERAPEUTICS CORPORATION 91307C102 06/26/2025 Advisory resolution to approve executive compensation SECTION 14A SAY-ON-PAY VOTES 4000 0 FOR 4000 FOR AKERO THERAPEUTICS, INC 00973Y108 06/03/2025 To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES 30207 0 FOR 30207 FOR BRIDGEBIO PHARMA, INC. 10806X102 06/20/2025 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 112156 0 FOR 112156 FOR NEWAMSTERDAM PHARMA COMPANY N.V. N62509109 06/01/2025 Non-binding, advisory vote to approve the 2024 compensation of named executive officers SECTION 14A SAY-ON-PAY VOTES 23154 0 FOR 23154 FOR FULCRUM THERAPEUTICS INC 359616109 06/26/2025 A non-binding advisory vote on executive compensation SECTION 14A SAY-ON-PAY VOTES 622887 0 FOR 622887 FOR GOSSAMER BIO, INC. 38341P102 06/25/2025 Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement SECTION 14A SAY-ON-PAY VOTES 1022115 0 FOR 1022115 FOR